Saliva-Based Glucose Testing | Tech Thursday

Courtesy of iQ Group Global’s website.

“Scientists have been in search of a more cost-effective, non-invasive, and accurate diabetes monitoring alternative to blood sugar testing.”

Is there a better way to check blood glucose than uncomfortable fingersticks?

For people with diabetes who use self-management of blood glucose (SMBG) to monitor diabetes progress, fingersticks can wear on one’s fingertips, emotional well-being, and bank account.

Even continuous glucose monitors (CGMs) that provide around-the-clock glucose information and reduce the need for fingersticks, help with finger fatigue. But for many, they are not an affordable option.

Is there another option to check one’s glucose that is less painful and accurate?

The answer could be saliva-based glucose readings.

“Lab tests of the saliva process have shown promising results with an accuracy rate of 95.2%. The research has been published in the journal PLOS ONE,” wrote Dr. Kamal Kant Kohli for Medical Dialogues.

Courtesy of iQ Group Global’s website.

Currently, companies like iQ Group Global and GBS inc. are developing Saliva Glucose Biosensors. This biosensor is a small strip that once matched with someone’s saliva offers an immediate glucose check and sends the results to an app on one’s phone.

Once these new systems are approved, it will be a game-changer.

Though saliva-based glucose testing has not yet hit the markets, for the millions of people that continue to perform finger sticks, we hope that saliva glucose testing will be available soon.

To read more, click here or visit iQ Group Global and GBS Inc websites.

Written by Catherine Cullinane RN, CDCES, our resident Tech Thursday Content Writer

Want more from Diana Isaacs?
Join her in her upcoming
Virtual Course Insulin Therapy, Pumps, & CGM + CV Risk Reduction Strategies
Earn 4.0 CEs | $69

Join Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, and ADCES 2020 Diabetes Educator of the year as she reviews these important topics. As Diabetes Specialists, we are tasked with taking a leadership role in technology and cardiovascular risk reduction. Dr. Isaacs will address these topics with clinical insight and expert knowledge during these two virtual courses.

Virtual Course Webinar Dates | Earn 4.0 CEs

Session 1 | CV Risk Management with Pharmacology and Intensive Insulin Therapy on May 13, 2020, from 12:30 PM – 2:30 PM (PDT)

Session 2 | Continuous Glucose Monitoring and Insulin Pump Therapy on May 14 from 8:30 AM – 10:30 AM (PDT)


  1. Describe critical teaching content before starting insulin pump therapy.
  2. Describe appropriate candidates for insulin pump therapy.
  3. Discuss strategies to determine and fine-tune insulin pump basal rates.
  4. Discuss how to determine and fine-tune bolus rates including coverage for carbs and hyperglycemia.
  5. State important safety measures to prevent hyperglycemic crises.
  6. List inpatient considerations for insulin pump therapy and CGMs.
  7. Discuss features of available professional and personal CGMs and insulin pumps.
  8. Describe CV risk factors associated with diabetes and future event prediction.
  9. List different pharmacologic approaches to mitigate CV events.

$69 | Earn 4 CEs

These sessions are also included in our Virtual Conference.

Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE!  Sign up below!